27 resultados.
The CIGB-Mariel biotechnological facility is the first operation of its kind in the Mariel Special Development Zone, financed with 100% Cuban capital and the product of a joint effort by our country’s technologists, engineers, designers and construction workers
COVID-19 vaccination in pediatric age groups is underway, as academic year begins with a view toward in-person classes
The Communist Party of China sends its Cuban counterpart a donation of protective supplies to support the country’s battle against COVID-19
Regarding subsidies that will be maintained, the Minister emphasized financing of the retail cost of food items guaranteed to children and pregnant women, as well as a basic layette for newborns, plus most medications
Foreign investment could help the national industry increase production and, in turn, supply at a faster rate.
Once expected approval by the Center for State Control of Medicines, Equipment and Medical Devices is granted, in the first days of March phase III clinical trials will begin of Cuba’s Abdala (CIGB-66) and Soberana 02 candidates vaccine against COVID-19, which have proven to be safe and effective in producing a powerful immune response to the virus
The trial includes 120 volunteers from the municipality of Centro Habana, between 19 and 80 years of age, who were discharged from the hospital at least two months, following a SARS-COV2 infection
A less complex and safer variant of the candidate vaccine under investigation, with a view toward boosting immunity of those who have already had a SARS-COV2 infection
The solution and improvement will be gradual, based on the resources that are being imported to manufacture the spare parts required by our thermoelectric power plants and generators
Dr. Vicente Vérez Bencomo, director of the Finlay Vaccine Institute, states that mass production of the Soberana series of candidate vaccines has begun, and one million doses will be on hand in April
